glp 1 and heart disease GLP-1 receptor agonists myocardial metabolism in atrial fibrillation Congratulations to the Division of

DelveInsights ' GLP Agonist Pipeline Insight 2024 ' report provides comprehensive global coverage of pipeline GLP agonists in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the GLP agonist pipeline domain

TheOffice of Dietary Supplements notes that B12 is key for energy and nerve health, making combo therapies a valuable option for some conditions

tirzepatide, early research suggests that retatrutide may lead to the greatest average weight loss

DPN is one of the microvascular complications of diabetes and shares pathophysiologic mechanisms of glucose-mediated vascular damage with other complications [5]

Acknowledgments We thank Molly Thompson for preparing the figures